We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current DXCM market cap is 44.7B. The company's latest EPS is USD 1.4046 and P/E is 82.55.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 741.5M | 871.3M | 975M | 1.03B | 921M |
| Operating Income | 47.2M | 128.1M | 206.5M | 217.6M | 101.1M |
| Net Income | 48.6M | 115.9M | 120.7M | 256.3M | 146.4M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.48B | 1.93B | 2.45B | 2.91B | 3.62B |
| Operating Income | 142.3M | 299.5M | 277.4M | 391.2M | 598.4M |
| Net Income | 101.1M | 493.6M | 154.7M | 341.2M | 541.5M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 5.52B | 6.82B | 6.6B | 6.26B | 6.48B |
| Total Liabilities | 3.28B | 4.72B | 4.33B | 4.2B | 4.24B |
| Total Equity | 2.23B | 2.1B | 2.27B | 2.07B | 2.25B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 2.4B | 4.29B | 4.86B | 5.39B | 6.26B |
| Total Liabilities | 1.51B | 2.46B | 2.61B | 3.26B | 4.2B |
| Total Equity | 882.6M | 1.83B | 2.25B | 2.13B | 2.07B |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 155.4M | 345.7M | 614.9M | 748.5M | 209.2M |
| Investing | -186.7M | -742.6M | -922.1M | -507.2M | 74.8M |
| Financing | 11.2M | 950.7M | 313.3M | -318.6M | 4.7M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 314.5M | 475.6M | 442.5M | 669.5M | 748.5M |
| Investing | -1.02B | -1.02B | -216.1M | -521.5M | -507.2M |
| Financing | 10.7M | 912.1M | 10.4M | -552.5M | -318.6M |
| Market Cap | 44.7B |
| Price to Earnings Ratio | 82.55 |
| Price to Sales Ratio | 12.34 |
| Price to Cash Ratio | 78.94 |
| Price to Book Ratio | 21.61 |
| Dividend Yield | - |
| Shares Outstanding | 385.52M |
| Average Volume (1 week) | 2.37M |
| Average Volume (1 Month) | 2.83M |
| 52 Week Change | -8.17% |
| 52 Week High | 142.00 |
| 52 Week Low | 74.75 |
| Spread (Intraday) | 57 (40.14%) |
| Company Name | DexCom Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.dexcom.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
